|Perfect Smile Corporation Appoints Daniel Kagan PhD to Board of Directors (07-21-11)|
2011-07-21 Perfect Smile Corporation
Jul 21, 2011 – Perfect Smile Corporation today announced the appointment of Daniel Kagan PhD to its Board of Directors. Dr. Kagan is a managing partner at BioActives LLC, a natural ingredient development company. BioActives LLC holds the patent for MicroActive® CoQ10, a water-soluble and highly bio-available form of CoQ10 for which Perfect Smile Corporation has the exclusive license for oral-care applications. MicroActive® CoQ10 has demonstrated its effectiveness in the only known clinical study of a toothpaste containing CoQ10. Gerald Patera, Perfect Smile’s President, stated that “Dr. Kagan will bring valuable business expertise to the Board of Directors and his appointment will also more closely align the objectives of both companies for further growth and development.” For more information about Perfect Smile products, please visit http://www.4theperfectsmile.com
About Perfect Smile Corporation
Perfect Smile’s product development began with the early recognition of CoQ10 and its role in fighting gum disease by two nationally known oral care professionals, a dentist specializing in cosmetic dentistry and an oral implant surgeon. In collaboration, they developed and brought to market the Perfect Smile Oral Care System comprised of its toothpaste, mouth rinse and chewing gum. Additionally, the company produces a teeth-whitening pen. Perfect Smile products are made in the USA and marketed to consumers through its website (www.4theperfectsmile.com). Perfect Smile also partners with various companies both online and offline who market products to their members and customers under the Perfect Smile brand and also through private label arrangements.
BioActives produces a variety of value-added nutritional ingredients, including MicroActive® CoQ10 which is marketed through Maypro Industries http://www.maypro.com as a nutritional supplement. MicroActive® technology is used to improve the bioavailability of lipophilic compounds as well as to reduce uptake variance inherent in these ingredients. MicroActive® ingredients assure consumers maximum efficacy regardless of diet, health conditions or risk factors. In addition, they are cost effective and easily formulated into many applications. The company also produces other cardio-care products such as Cardio HB, a hibiscus extract, and a celery-seed extract standardized to 85% phthalides. http://www.bioactives.com